Pre-clinical studies reported at the annual meeting of the American Association of Cancer Research on April 16, 2007 show that  the chemotherapy drug Onconase significantly inhibits tumor growth in non-small cell lung cancer and breast cancer. Onconase is also subject to an ongoing Phase IIIb study in malignant mesothelioma, a form of cancer linked to
Pre-clinical […]